Injectable Peptides Bodybuilding Supplements Lyophilized Powder Tesamorelin CAS

Top Service Injectable Peptide Lyophilized Powder Tesamorelin 218949-48-5 for Bodybuilding

Basic Info

CAS: 218949-48-5
Customized: Non-Customized
Suitable for: Elderly, Adult
Purity: >99%
Molecular Formula: C211h366n72o67s1
Appearance: White Powder
Specification: Qualified
HS Code: 2937290018
Powder: Yes
Certification: HSE, ISO 9001, USP, BP
State: Solid
CAS: 218949-48-5
Molecular Weight: 5135.89
Express: EMS, DHL, TNT, UPS, FedEx
Transport Package: According to Every Customers′s Requirements
Origin: China
Factory Price 99.5% Body Building Polypeptide Tesamorelin (2mg/ Vial)

Description:

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin ( also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
p; tendon fibroblasts in a dose-dependent manner as revealed by transwell filter migration assay. BPC 157 also dose dependently accelerated the spreading of tendon fibroblasts on culture dishes. The F-actin formation as detected by FITC-phalloidin staining was induced in BPC 157-treated fibroblasts. The protein expression and activation of FAK and paxillin were determined by Western blot analysis, and the phosphorylation levels of both FAK and paxillin were dose dependently increased by BPC 157 while the total amounts of protein was unaltered. In conclusion, BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration of tendon fibroblasts, which is likely mediated by the activation of the FAK-paxillin pathway.
nbsp; was responsible for pituitary stimulation. In 1999 researchers Goa and Prakash checked sermorelin GH as provocative tasting method for deficiency of endogenous G-hormone.
The most known features of this research compound are increasing lean muscular tissue mass, reducing fat, increasing bone tissue density and even enhancing functioning of immune system. It complies with certain amino-segment of natural long-chained GHrh. Sermorelin helps to convert exceeded volume of GH by liver into IGF-1.

Applications

Tesamorelin is made with growth hormone-releasing factor (GRF).Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).Tesamorelin is not a weight-loss medication and should not be used to treat obesity.

Tesamorelin is the only FDA drug approved for the intended reduction of abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection. It stimulates the bodys release of growth hormone, which is reduced in HIV lipodystrophy.

Those who are infected with the HIV virus must sometimes deal with a health issue which is known as
lipodystrophy. This is a syndrome which is triggered by different causes. Certain people with this health issue (one in four of HIV patients), experience fat loss - however, others experience weight gain in key areas, including the throat, the chest (or breasts) and the tummy. In addition to this weight gain, increased blood fat levels and differences in insulin levels may be present.

Tesamorelin is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date, clinical studies suggest that Tesamorelin reduces visceral fat in HIV-infected patients with abdominal lipo-hypertrophy as well as reducing abdominal fat in all individuals studied.

A peptide that increases growth hormone release improved several measures of cognitive function in cognitively normal and mildly impaired older individuals in a placebo-controlled trial, a researcher said here. Scores on standard tests of executive function and verbal memory were significantly higher in participants given tesamorelin (Egrifta), a synthetic analog of growth hormone releasing hormone (GHRH), in a 20-week trial, according to Laura D. Baker, PhD.. Participants taking the drug in the 78-person trial also reported greater subjective improvement in cognition relative to the placebo group.

Who should not use tesamorelin?

Given the potential for developing cancer when using tesamorelin, individuals should be screened and assessed for current or possible new cancers. People should weigh the risks and benefits before making decisions to start on the drug. Tesamorelin has not been studied in children.

Pregnant women and people with an active cancer should not use it. People going through cancer treatment should wait until their therapy has stopped and it’s clear that the cancer has become inactive before starting tesamorelin. Also, anyone with earlier head trauma, radiation of the head, or issues regarding the pituitary gland should not use the drug.

Since clinical study beyond a year has not been done, it’s unknown what long-term side effects may occur, including heart health. In people who start tesamorelin but do not show clear improvement in their deep belly fat and longer-term use may be questionable, it may be wise to stop using the drug.

How to make the injectable Tesamorelin?

Tesamorelin comes in a dried format and it’s meant to be reconstituted with sterile water before being injected. Full instructions should be included with each vial of Tesamorelin. To reconstitute this lyophilized powder, add 2.1 milliliters of diluent and then combine both ingredients by carefully rolling the tube within your hands for half a minute. Don’t shake the mixture before you use it. Being too aggressive while mixing it may damage its efficacy and this is why it must be handled gently at all times.

If you have any questions, pls feel free to contact me:

Email:pennsy (at) chembj (dot) com
Whatsapp:+8618872220800
Website: http://www.legalanabolic-steroids.com

I will reply you with best price and service at soonest time.
Thank you and welcome your inquiry!